Form 4: Arcutis Biotherapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Patrick Burnett, Senior Vice President and Chief Medical Officer of Arcutis Biotherapeutics, sold 15,441 shares of common stock to cover tax obligations related to vesting Restricted Stock Units.
Summary
- On November 4, 2024, Patrick Burnett, Senior Vice President and Chief Medical Officer of Arcutis Biotherapeutics, sold 15,441 shares of the company's common stock.
- The sale was executed to satisfy tax withholding obligations associated with the vesting of Burnett's Restricted Stock Units (RSUs).
- The shares were sold at a weighted average price of $8.6842, with individual transactions ranging from $8.32 to $8.86.
- Following the transaction, Burnett directly owns 179,418 shares of Arcutis Biotherapeutics.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations, not indicative of positive or negative sentiment towards the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives. This transaction is a routine event and doesn't necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 11/04/2024 | Date of the stock sale transaction. |
| 11/05/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.